Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-02

FDA Approved: VIGABATRIN — Supplemental Application (Dr. Reddys Laboratories Inc.,)

View source ↗

Summary

FDA granted a supplemental approval for Vigabatrin by Dr. Reddys Laboratories Inc., initiating a new regulatory action related to the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)